Literature DB >> 4016141

Effects of antimalarial drugs on phospholipase A and lysophospholipase activities in plasma membrane, mitochondrial, microsomal and cytosolic subcellular fractions of rat liver.

B M Löffler, E Bohn, B Hesse, H Kunze.   

Abstract

Activities of membrane-associated phospholipases A1 and A2, and membrane-associated as well as soluble lysophospholipases were measured in different subcellular fractions of rat liver, using suspensions of stereospecifically labelled radioactive phospholipids as substrates. Plasma membranes and endoplasmic reticulum were shown to contain phospholipase A1 and lysophospholipase activities, both of which could be stimulated by Ca2+, mitochondria Ca2+-dependent phospholipase A2 and cytosol Ca2+-independent lysophospholipase activities. Each of these lipolytic enzymes could be inhibited by antimalarial drugs (chloroquine, mepacrine, primaquine) at concentrations above 1 x 10(-4) M. Inhibition of the alkaline cytosolic lysophospholipase by these drugs was noncompetitive with respect to the substrate, and the inhibitory potency increased, when the pH was raised.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016141     DOI: 10.1016/0005-2760(85)90114-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

Review 1.  The role of antimalarial agents in the treatment of SLE and lupus nephritis.

Authors:  Senq-J Lee; Earl Silverman; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

2.  Store-activated Ca2+ inflow in Xenopus laevis oocytes: inhibition by primaquine and evaluation of the role of membrane fusion.

Authors:  R B Gregory; G J Barritt
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

3.  Identification of activators of ERK5 transcriptional activity by high-throughput screening and the role of endothelial ERK5 in vasoprotective effects induced by statins and antimalarial agents.

Authors:  Nhat-Tu Le; Yuichiro Takei; Yuki Izawa-Ishizawa; Kyung-Sun Heo; Hakjoo Lee; Alan V Smrcka; Benjamin L Miller; Kyung Ae Ko; Sara Ture; Craig Morrell; Keigi Fujiwara; Masashi Akaike; Jun-ichi Abe
Journal:  J Immunol       Date:  2014-09-03       Impact factor: 5.422

4.  Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug design.

Authors:  L W Scheibel; P M Colombani; A D Hess; M Aikawa; C T Atkinson; W K Milhous
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

5.  Effects of the phospholipase inhibitor mepacrine on injury in ischemic and metabolically inhibited adult isolated myocytes.

Authors:  S C Armstrong; C E Ganote
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

6.  Association between inhibition of arachidonic acid release and prevention of calcium loading during ATP depletion in cultured rat cardiac myocytes.

Authors:  R L Jones; J C Miller; H K Hagler; K R Chien; J T Willerson; L M Buja
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

7.  Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro.

Authors:  M T Labro; C Babin-Chevaye
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

Review 8.  New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.

Authors:  Katerina Gurova
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

9.  Late preventive effects of quinacrine on carbon tetrachloride induced liver necrosis.

Authors:  A González Padrón; E G de Toranzo; J A Castro
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

10.  Early metabolic inhibition-induced intracellular sodium and calcium increase in rat cerebellar granule cells.

Authors:  W H Chen; K C Chu; S J Wu; J C Wu; H A Shui; M L Wu
Journal:  J Physiol       Date:  1999-02-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.